{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:30:04Z","timestamp":1790508604905,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.xphs.2021.06.018","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:41:01Z","timestamp":1623458461000},"page":"3457-3463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Solid-State Overview of R-Baclofen: Relative Stability of Forms A, B and C and Characterization of a New Heterosolvate"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5878-2696","authenticated-orcid":false,"given":"Nicolas","family":"Couvrat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Sanselme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Poupard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bensakoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon H.","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Coquerel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2021.06.018_bib0001","series-title":"Polymorphism in the Pharmaceutical Industry: Solid Form and Drug Development","year":"2019"},{"issue":"4","key":"10.1016\/j.xphs.2021.06.018_bib0002","first-page":"163","article-title":"A practical guide to pharmaceutical polymorph screening & selection","volume":"9","author":"Lee","year":"2014","journal-title":"Asian J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2021.06.018_bib0003","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1021\/cg801361m","article-title":"Two Concomitant Polymorphs of 1,2-Naphthoquinone-2-semicarbazone","volume":"9","author":"Dureisseix","year":"2009","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2021.06.018_bib0004","first-page":"291","article-title":"Identifying the stable polymorph early in the drug discovery\u2013development process","volume":"10","author":"Miller","year":"2005","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"10.1016\/j.xphs.2021.06.018_bib0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1021\/acs.cgd.5b01384","article-title":"Access to Several Polymorphic Forms of (\u00b1)-Modafinil by using various solvation\u2013desolvation processes","volume":"16","author":"Mahieux","year":"2016","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2021.06.018_bib0006","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.addr.2003.10.020","article-title":"High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids","volume":"56","author":"Morissette","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2021.06.018_bib0007","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1039\/c2ce06537a","article-title":"Physical transformations of the active pharmaceutical ingredient BN83495: enantiotropic and monotropic relationships. Access to several polymorphic forms by using various solvation\u2013desolvation processes","volume":"14","author":"Martins","year":"2012","journal-title":"CrystEngComm"},{"key":"10.1016\/j.xphs.2021.06.018_bib0008","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1039\/c2cp40128b","article-title":"The crystalline state of methylene blue: a zoo of hydrates","volume":"14","author":"Rager","year":"2012","journal-title":"PCCP"},{"issue":"9","key":"10.1016\/j.xphs.2021.06.018_bib0009","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1021\/acs.cgd.8b00331","article-title":"A possible infinite number of components in a single crystalline phase: on the isomorphism of brivaracetam\u2013guest molecules","volume":"18","author":"Couvrat","year":"2018","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2021.06.018_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119902","article-title":"Kinetics and mechanism of polymorphic transformation of sorbitol under mechanical milling","volume":"590","author":"Dupont","year":"2020","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2021.06.018_bib0011","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1021\/acs.cgd.0c00441","article-title":"Characterization of unknown solid states of the drug substance quinacrine dihydrochloride: two anhydrous forms and a tetrahydrate revealed","volume":"20","author":"Rotival","year":"2020","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2021.06.018_bib0012","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/ceat.201400692","article-title":"Crystallization of Terutroban sodium salt hydrate from the deliquescent state","volume":"38","author":"Couvrat","year":"2015","journal-title":"Chem Eng Technol"},{"issue":"10","key":"10.1016\/j.xphs.2021.06.018_bib0013","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cep.2005.10.011","article-title":"The \u2018structural purity\u2019 of molecular solids\u2014An elusive concept?","volume":"45","author":"Coquerel","year":"2006","journal-title":"Chem Eng Process"},{"key":"10.1016\/j.xphs.2021.06.018_bib0014","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/1352458504ms1085oa","article-title":"Prevalence and treatment of spasticity reported by multiple sclerosis patients","volume":"10","author":"Rizzo","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.xphs.2021.06.018_bib0015","article-title":"Baclofen for alcohol use disorder","volume":"11","author":"Minozzi","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xphs.2021.06.018_bib0016","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3389\/fpsyt.2018.00708","article-title":"The use of Baclofen as a treatment for alcohol use disorder: a clinical practice perspective","volume":"9","author":"de Beaurepaire","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.xphs.2021.06.018_bib0017","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/jps.20894","article-title":"Solid-state properties and relationship between anhydrate and monohydrate of baclofen","volume":"96","author":"Mirza","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2021.06.018_bib0018","doi-asserted-by":"crossref","first-page":"C71","DOI":"10.1107\/S0108767381097432","article-title":"The crystal structures of (S) and (R) baclofen and carbamazepine","volume":"37","author":"Chang","year":"1981","journal-title":"Acta Crystallogr, Sect A"},{"key":"10.1016\/j.xphs.2021.06.018_bib0019","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1107\/S0567740882007973","article-title":"Structure and absolute configuration of (R)-baclofen mono\u00adhydrochloride","volume":"38","author":"Chang","year":"1982","journal-title":"Acta Crystallographica Section B"},{"issue":"8","key":"10.1016\/j.xphs.2021.06.018_bib0020","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1021\/acs.cgd.9b00665","article-title":"Resolution of Baclofenium Hydrogenomaleate by using preferential crystallization. A first case of complete solid solution at high temperature and a large miscibility gap in the solid state","volume":"19","author":"Gendron","year":"2019","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2021.06.018_bib0021","unstructured":"T Miki, M Takeda, T Yamazaki, Optically Active 4-amino-3-(4-chlorophenyl) butanoic acid. US Patent no. US8669395, March 11, 2014."},{"key":"10.1016\/j.xphs.2021.06.018_bib0022","unstructured":"J Yasuoka, S Fukuyo, T Ikemoto, Method of Producing Optically Active 4-Amino-3-Substituted Phenylbutanoic Acid, US Patent no US20090137819, May 28, 2009."},{"issue":"4","key":"10.1016\/j.xphs.2021.06.018_bib0023","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1039\/a606037d","article-title":"Optical resolution of baclofen via diastereomeric salt pair formation between 3-(p-chlorophenyl)glutaramic acid and (S)-(-)-\u03b1-phenylethylamine","volume":"2","author":"Caira","year":"1997","journal-title":"J Chem Soc Perkin Trans"},{"issue":"3","key":"10.1016\/j.xphs.2021.06.018_bib0024","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1124\/jpet.108.149773","article-title":"Arbaclofen Placarbil, a Novel R-Baclofen prodrug: improved absorption, distribution, metabolism, and elimination properties compared with R-baclofen","volume":"330","author":"Lal","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.xphs.2021.06.018_bib0025","unstructured":"Biovia Material Studio 2019 (19.1.0.2353), Copyright (c) 2018 Dassault Syst\u00e8mes, all right reserved. Available at: http:\/\/accelrys.com\/products\/collaborative-science\/biovia-materials-studio. Accessed July 22, 2021."},{"key":"10.1016\/j.xphs.2021.06.018_bib0026","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1107\/S0021889802023348","article-title":"X-Cell: a novel indexing algorithm for routine tasks and difficult cases","volume":"36","author":"Neumann","year":"2003","journal-title":"J Appl Crystallogr"},{"key":"10.1016\/j.xphs.2021.06.018_bib0027","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1107\/S0021889881009618","article-title":"Unit-cell refinement from powder diffraction scans","volume":"14","author":"Pawley","year":"1981","journal-title":"J Appl Crystallogr"},{"key":"10.1016\/j.xphs.2021.06.018_bib0028","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1107\/S0021889899009930","article-title":"PowderSolve \u2013 a complete package for crystal structure solution from powder diffraction patterns","volume":"32","author":"Engel","year":"1999","journal-title":"J Appl Crystallogr"},{"key":"10.1016\/j.xphs.2021.06.018_bib0029","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1107\/S0021889869006558","article-title":"A profile refinement method for nuclear and magnetic structures","volume":"2","author":"Rietveld","year":"1969","journal-title":"J Appl Crystallogr"},{"key":"10.1016\/j.xphs.2021.06.018_bib0030","doi-asserted-by":"crossref","unstructured":"A Burger, R Ramburger, On the polymorphism of pharmaceuticals and other molecular crystals. I, Microchimica Acta, 1979, 72, 259\u2013271. 10.1007\/BF01197379","DOI":"10.1007\/BF01197379"},{"issue":"23","key":"10.1016\/j.xphs.2021.06.018_bib0031","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/(SICI)1521-3773(19991203)38:23<3440::AID-ANIE3440>3.0.CO;2-#","article-title":"Concomitant Polymorphs","volume":"38","author":"Bernstein","year":"1999","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.xphs.2021.06.018_bib0032","series-title":"Polymorphism in the Pharmaceutical Industry: Solid Form and Drug Development","first-page":"91","article-title":"The thermodynamics of polymorphs and solvates","author":"Coquerel","year":"2019"},{"key":"10.1016\/j.xphs.2021.06.018_bib0033","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1039\/C3CS60359H","article-title":"Crystallization of molecular systems from solution: phase diagrams, supersaturation and other basic concepts","volume":"43","author":"Coquerel","year":"2014","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.xphs.2021.06.018_bib0034","unstructured":"G Coquerel, M Sanselme, A Lafontaine, Method of Measuring Scattering of x-Rays, its Applications and Implementation Device, Patent no WO\/2012\/136921, 2012."},{"key":"10.1016\/j.xphs.2021.06.018_bib0035","article-title":"Simplification of the landscape under high energy milling of molecular solids exhibiting polymorphism","author":"Linol","year":"2009","journal-title":"JEEP \u2013 Journ\u00e9es d'Etude des Equilibres Entre Phases 00013"},{"issue":"23","key":"10.1016\/j.xphs.2021.06.018_bib0036","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1023\/A:1026751017284","article-title":"Polymorphic transformation and powder characteristics of TiO2 during high energy milling","volume":"35","author":"Ren","year":"2000","journal-title":"J Mater Sci"},{"key":"10.1016\/j.xphs.2021.06.018_bib0037","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1021\/acs.cgd.7b01283","article-title":"Structural transformations of D-Mannitol induced by in situ milling using real time powder synchrotron radiation diffraction","volume":"17","author":"Martinetto","year":"2017","journal-title":"Cryst Growth Des"},{"issue":"3","key":"10.1016\/j.xphs.2021.06.018_bib0038","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.cherd.2013.09.011","article-title":"The influence of spiral jet-milling on the physicochemical properties of carbamazepine form III crystals: quality by design approach","volume":"92","author":"Djoki\u0107","year":"2014","journal-title":"Chem Eng Res Des"},{"issue":"8","key":"10.1016\/j.xphs.2021.06.018_bib0039","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1021\/acs.cgd.6b01160","article-title":"Stability of pharmaceutical cocrystal during milling: a case study of 1:1 Caffeine\u2013Glutaric Acid","volume":"17","author":"Shan Chow","year":"2017","journal-title":"Cryst Growth Des"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921003099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921003099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:35:41Z","timestamp":1758360941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921003099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0022354921003099"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.06.018","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solid-State Overview of R-Baclofen: Relative Stability of Forms A, B and C and Characterization of a New Heterosolvate","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}